CRISPR/Cas systems usher in a new era of disease treatment and diagnosis

CRISPR/Cas systems usher in a new era of disease treatment and diagnosis

Abstract The discovery and development of the CRISPR/Cas system is a milestone in precise medicine. CRISPR/Cas nucleases, base-editing (BE) and prime-editing (PE) are three genome editing technologies derived from CRISPR/Cas. In recent years, CRISPR-based genome editing technologies have created imm...

Full description

Bibliographic Details
Main Authors: Ruiting Li, Qin Wang, Kaiqin She, Fang Lu, Yang Yang
Format: Article
Language:English
Published: Springer 2022-10-01
Series:Molecular Biomedicine
Subjects:
CRISPR
Base editing
Prime editing
Gene therapy
Molecular diagnosis
Online Access:https://doi.org/10.1186/s43556-022-00095-y

Internet

https://doi.org/10.1186/s43556-022-00095-y

Similar Items